Acute Pseudophakic Cystoid Macular Edema Treatment Trial: Intravitreal Ranibizumab Versus Triamcinolone Acetonide
Phase of Trial: Phase I/II
Latest Information Update: 27 Apr 2017
At a glance
- Drugs Ranibizumab (Primary) ; Triamcinolone
- Indications Retinal oedema
- Focus Adverse reactions
- 24 Apr 2017 Planned End Date changed from 1 Nov 2017 to 1 Nov 2020.
- 24 Apr 2017 Planned primary completion date changed from 1 Nov 2016 to 1 Nov 2019.
- 18 May 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.